These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25385405)

  • 1. Need to clarify the cause of hemolysis in case report of newborn with clinically significant hemolytic disease and passive transfer of anti-D from maternal RhIG.
    Watchko JF; Triulzi D
    Transfusion; 2014 Nov; 54(11):3017-8. PubMed ID: 25385405
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG.
    Cohen DN; Johnson MS; Liang WH; McDaniel HL; Young PP
    Transfusion; 2014 Nov; 54(11):2863-6. PubMed ID: 24826985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 5. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease due to antibodies other than anti-D.
    LEVINE P
    Rev Hematol; 1955; 10(2):215-26; discussion, 256-64. PubMed ID: 13255416
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies of red cell fragility in anti-D hemolytic disease of the newborn.
    GREENWALT TJ; TRIANTAPHYLLOPOULOS DC
    J Lab Clin Med; 1955 Jan; 45(1):135-40. PubMed ID: 13233638
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG.
    Walhof ML; Leon J; Greiner AL; Scott JR; Knudson CM
    J Clin Lab Anal; 2022 Apr; 36(4):e24323. PubMed ID: 35243688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte glycolysis in erythroblastotic newborns. Erythrocyte glycolysis also in Rh-positive red cells coated with anti-D antibodies.
    ABRAHAMOV A; DIAMOND LK
    AMA J Dis Child; 1960 Feb; 99():202-5. PubMed ID: 13791535
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk.
    Li M; Blaustein JC
    Transfusion; 2017 Sep; 57(9):2121-2124. PubMed ID: 28580721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABC of transfusion. Haemolytic disease of the newborn and its prevention.
    Tovey LA
    BMJ; 1990 Feb; 300(6720):313-6. PubMed ID: 2155679
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn with rarely occurring blood group antibodies].
    Dzierzkowa-Borodej W; Olearczyk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):366-8. PubMed ID: 4193016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.